ATARA BIOTHERAPEUTICS INC (ATRA) Stock Income Statement
NASDAQ:ATRA - Nasdaq - US0465132068 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 199.73M | 128.94M | 8.57M | 63.57M | 20.34M | |||
| Cost Of Goods | 39.46M | 21.01M | 8.89M | N/A | N/A | |||
| Gross Profit | 160.27M | 107.93M | -313.00K | N/A | N/A | |||
| Operating Expenses | 159.39M | 186.26M | 268.96M | 338.13M | 360.80M | |||
| Research and Development | 120.61M | 147.73M | 219.17M | 269.99M | 282.00M | |||
| Selling, General, and Administrative Expenses | 38.78M | 38.53M | 49.80M | 68.13M | 78.80M | |||
| Operating Income | 880.00K | -78.33M | -269.28M | -274.55M | -340.46M | |||
| Interest Income/Expense | -2.74M | -2.50M | 141.00K | 1.99M | 370.00K | |||
| Other Income/Expense | 449.00K | 528.00K | -246.00K | N/A | N/A | |||
| Non Recurring Items | -14.27M | -5.11M | -6.73M | -5.96M | N/A | |||
| Income Before Taxes | -15.68M | -85.42M | -276.11M | -228.29M | -340.10M | |||
| Income Tax | -36.00K | -12.00K | 15.00K | 10.00K | 50.00K | |||
| Net Income | -15.64M | -85.40M | -276.13M | -228.30M | -340.14M | |||
| EBITDA | 6.33M | -73.28M | -264.45M | -268.90M | -331.11M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.50 | -11.41 | -65.18 | -2.24 | -3.63 | |||
| Non GAAP EPS | -3.72 | -12.97 | -65.50 | -68.00 | -90.75 | |||
| Statistics | ||||||||
| Gross Profit Margin | 80.24% | 83.71% | -3.65% | N/A | N/A | |||
| Profit Margin | -7.83% | -66.23% | -3220.88% | -359.13% | -1672.27% | |||
| Operating Profit Margin | 0.44% | -60.75% | -3140.98% | -431.89% | -1673.84% | |||
All data in USD